Imanix

400 mg

Imanix 400 mg is a tyrosine kinase inhibitor manufactured by Beacon Pharmaceuticals Ltd. It contains imatinib mesylate, a targeted therapy used in oncology 

---

🧫 Mechanism of Action

• Inhibits BCR‑ABL tyrosine kinase, the abnormal enzyme produced by the Philadelphia chromosome in chronic myeloid leukemia (CML).

• Also targets c-KIT and PDGF receptors, crucial in other cancers like GI stromal tumors (GIST) and hypereosinophilic syndrome.

---

✅ Approved Indications

Imanix 400 mg is indicated for treatment in:

• Chronic myeloid leukemia (Ph+ CML) across chronic, accelerated, and blast phases

• Acute lymphoblastic leukemia (Ph+ ALL)

• Gastrointestinal stromal tumors (GIST) — unresectable, metastatic, or adjuvant

• Myelodysplastic/myeloproliferative diseases, systemic mastocytosis, hypereosinophilic syndrome/chronic eosinophilic leukemia, dermatofibrosarcoma protuberans, and more 

---

💊 Dosage & Administration

• Pediatric dosing: typically 340 mg/m²/day 

• Taken with food and a large glass of water. 800 mg doses are split (400 mg twice daily) to optimize absorption.

---

⚠️ Precautions & Interactions

• CYP3A4 metabolism: strong inducers reduce levels; strong inhibitors (e.g., grapefruit juice) increase levels. Adjust dosage accordingly.

• May interact with warfarin and other CYP-metabolized drugs — monitor closely.

---

📋 Pharmacokinetics

• Bioavailability: ~98%, with peak plasma levels in 2–4 hours.

• Protein binding: ~95%.

• Half-life: ~18 hours; active metabolite CGP74588 ~40 hours.

• Excretion: ~81% within 7 days, mostly fecal, some urinary.

---

💾 Storage & Handling

• Store < 30 °C, in a cool, dry, light‑protected place. Keep out of children’s reach.

---

⚕️ Side Effects & Patient Advice

Common side effects include:

• Gastrointestinal issues (nausea, diarrhea, abdominal pain)

• Fatigue, muscle cramps, edema, rash

Important guidance:

• Avoid breastfeeding and pregnancy unless absolutely necessary 

• Caution for liver or kidney impairment; dose adjustment may be needed 

• May cause dizziness—avoid driving until response is known

• Skip missed doses; do not double dose.